Medindia

X

FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere

by Medindia Content Team on  March 24, 2006 at 7:47 PM Corporate News   - G J E 4
FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere
French drug maker Sanofi-Aventis SA announced on Thursday that the US Food and Drug Administration has approved its cancer drug Taxotere to treat patients with stomach cancer. This approval means that Taxotere can be used in combination with chemotherapy drugs cisplatin and 5-fluorouracil to treat stomach cancers that have not been treated with chemotherapy.

Advertisement
Taxotere is also approved to treat some types of breast cancer and lung cancer. Certain types of prostate cancer can also be treated with the drug when used in combination with prednisolone. Sanofi-Aventis SA was able to speed up the review process after data from a late-stage clinical trial showed that the survival period increased when taxotere was used. Advanced or spreading stomach cancer does not have a big survival period.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All